MedTrace Logo

Understanding Vape Marketing Study

NCT07129265 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2025-08-19

No results posted yet for this study

Summary

The purpose of this study is to develop an electronic cigarette (e-cigarette) counter-marketing lesson for adolescents. The lesson will involve short videos designed to improve adolescents' cognition of e-cigarette marketing in the retail environment with the overall goal of reducing their susceptibility to use, intent to use, and actual use of e-cigarettes. Through this study, the study team will identify and refine the key messages that would make this lesson acceptable, feasible to implement, and effective in altering e-cigarette-related perceptions and potentially behaviors.

Conditions

  • E-cigarette
  • Vaping
  • Tobacco
  • Nicotine
  • Adolescent Behavior
  • Video Information
  • Digital Education Interventions

Interventions

OTHER

Working group

Participants will: 1) take a 10-min demographic survey; 2) join 3 x 60-min working group meetings in which they will review preliminary results, collaborate on curriculum design, and provide feedback; and 3) respond to prompts in 3 emails (approx 5-10 mins each).

OTHER

Focus group

Participants will take a 10-min demographic survey and join 1 x 30-min focus group meeting in which they will provide feedback on the curriculum in development.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Dana-Farber/Harvard Cancer Center (DF/HCC) Boston, MA

    collaborator UNKNOWN

  • Boston Children's Hospital

    lead OTHER

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07129265 on ClinicalTrials.gov